An immunocompetent rectal cancer model to study radiation therapy
暂无分享,去创建一个
S. Lowe | C. Sawyers | Seo-Hyun Choi | P. Paty | K. Lawrence | Ching-Tung Chen | J. Shia | P. Romesser | Chao Wu | Francisco M. Barriga | Jin K. Kim | Michael Del Latto | Yajing Gao | Maria Kierstead | Almudena Chaves Perez | Jussi K. Sillanpáá | J. Smith | Charles-Etienne Gabriel Sauvé | J. García-Aguilar | C. Firat | J. Wilkinson
[1] F. Buettner,et al. Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer. , 2022, Cancer cell.
[2] Pengfei Xu,et al. Global colorectal cancer burden in 2020 and projections to 2040 , 2021, Translational oncology.
[3] A. Durán,et al. Mouse model of colorectal cancer: orthotopic co-implantation of tumor and stroma cells in cecum and rectum , 2021, STAR protocols.
[4] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[5] I. Fichtner,et al. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine , 2020, Neoplasia.
[6] T. Ashizawa,et al. Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients , 2020, Journal of radiation research.
[7] P. Buckhaults,et al. Early-onset colorectal cancer: initial clues and current views , 2020, Nature Reviews Gastroenterology & Hepatology.
[8] E. Hau,et al. Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer , 2020, Frontiers in Cell and Developmental Biology.
[9] Jessica A Lavery,et al. A rectal cancer organoid platform to study individual responses to chemoradiation , 2019, Nature Medicine.
[10] S. Lowe,et al. Preclinical murine platform to evaluate therapeutic countermeasures against radiation-induced gastrointestinal syndrome , 2019, Proceedings of the National Academy of Sciences.
[11] M. Leclerc,et al. Mucosal healing progression after acute colitis in mice , 2019, World journal of gastroenterology.
[12] E. Giovannucci,et al. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies , 2019, Nature Reviews Gastroenterology & Hepatology.
[13] J. Ferlay,et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. , 2019, The lancet. Gastroenterology & hepatology.
[14] S. Carter,et al. Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer , 2019, Clinical Cancer Research.
[15] Jeffrey S. Morris,et al. Clinical and molecular characterization of early‐onset colorectal cancer , 2019, Cancer.
[16] V. Zadnik,et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years , 2019, Gut.
[17] I. Melero,et al. TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies , 2019, Molecular Cancer Therapeutics.
[18] S. Ellsworth. Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors , 2018, Advances in radiation oncology.
[19] D. Margolin,et al. An Optimal Orthotopic Mouse Model for Human Colorectal Cancer Primary Tumor Growth and Spontaneous Metastasis , 2018, Diseases of the colon and rectum.
[20] Y. Baskın,et al. Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature , 2018, Gastroenterology research.
[21] H. Begthel,et al. A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression , 2018, Nature Protocols.
[22] Adam Akkad,et al. Colonoscopy-based colorectal cancer modeling in mice with CRISPR–Cas9 genome editing and organoid transplantation , 2018, Nature Protocols.
[23] Philip S Rosenberg,et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013 , 2017, Journal of the National Cancer Institute.
[24] Teng Han,et al. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer , 2017, Nature Biotechnology.
[25] Francisco J. Sánchez-Rivera,et al. In vivo genome editing and organoid transplantation models of colorectal cancer , 2017, Nature Biotechnology.
[26] Zachary J. Heins,et al. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. , 2016, Gastroenterology.
[27] C. Poremba,et al. Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice , 2016, Clinical & Experimental Metastasis.
[28] M. Uchihashi,et al. Surgical Correction of Rectal Prolapse in Laboratory Mice (Mus musculus). , 2015, Journal of the American Association for Laboratory Animal Science : JAALAS.
[29] Hans Clevers,et al. Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer , 2015, Cell.
[30] Hans Clevers,et al. Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.
[31] M. Gönen,et al. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. , 2014, Journal of the National Cancer Institute.
[32] B. Chassaing,et al. Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.
[33] M. Bouvet,et al. Development of a Clinically-Precise Mouse Model of Rectal Cancer , 2013, PloS one.
[34] K. Schäkel,et al. Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. , 2013, Cancer cell.
[35] W. Oyen,et al. Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer , 2012, The Journal of Nuclear Medicine.
[36] S. Ichinose,et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell , 2012, Nature Medicine.
[37] P. Snyder,et al. Generation of a Transgenic Mouse for Colorectal Cancer Research with Intestinal Cre Expression Limited to the Large Intestine , 2010, Molecular Cancer Research.
[38] Umar Mahmood,et al. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.
[39] K. Zatloukal,et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Laurence Zitvogel,et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.
[41] Markus F Neurath,et al. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.
[42] D. Treanor,et al. Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer , 2005, Histopathology.
[43] K. Nomoto,et al. A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells , 2004, Cancer science.
[44] Takuji Tanaka,et al. A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate , 2003, Cancer science.
[45] J. Coxhead,et al. Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[46] N. Ikekawa,et al. Inhibition of HT-29 human colon cancer growth under the renal capsule of severe combined immunodeficient mice by an analogue of 1,25-dihydroxyvitamin D3, DD-003. , 1994, Cancer research.
[47] 油井 史郎. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5⁺ stem cell , 2011 .